SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000898432-24-000009
Filing Date
2024-01-03
Accepted
2024-01-03 16:30:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A sc13d-a.htm SC 13D/A 63617
  Complete submission text file 0000898432-24-000009.txt   64962
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 24507010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BLVD BRIDGEWATER NJ 08807
Business Address
Patel Gautam (Filed by) CIK: 0001738054 (see all company filings)

Type: SC 13D/A